Reliable imaging techniques to assist in the diagnosis of prostate cancer (PCa) were not available until the advent of multiparametric magnetic resonance imaging (mpMRI), which has been shown to improve… Click to show full abstract
Reliable imaging techniques to assist in the diagnosis of prostate cancer (PCa) were not available until the advent of multiparametric magnetic resonance imaging (mpMRI), which has been shown to improve the detection and characterization of prostate lesions. In 2018, the Australian Medicare Benefits Schedule (MBS) extended its coverage to include mpMRI for PCa diagnosis and surveillance.
Keywords:
impact australian;
prostate;
australian federal;
federal funding;
referral patterns;
funding referral
Journal Title: ANZ Journal of Surgery
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: ANZ Journal of Surgery
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!